Chengpeng Yu

Hubei Key Laboratory Of Hepato Pancreato Biliary Diseases
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression.

The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression.

Journal: Cell death & disease

Published: February 10, 2025

N6-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis.

N6-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis.

Journal: Journal of translational medicine

Published: August 11, 2024

LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis.

LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis.

Journal: Cellular signalling

Published: July 20, 2023

Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.

Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.

Journal: Journal of cellular and molecular medicine

Published: December 01, 2022

RHO GTPase family in hepatocellular carcinoma.

RHO GTPase family in hepatocellular carcinoma.

Journal: Experimental hematology & oncology

Published: August 23, 2022

Emerging roles of TRIM27 in cancer and other human diseases.

Emerging roles of TRIM27 in cancer and other human diseases.

Journal: Frontiers in cell and developmental biology

Published: July 27, 2022

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses.

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses.

Journal: Frontiers in immunology

Published: July 18, 2022

Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker.

Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker.

Journal: International immunopharmacology

Published: May 17, 2022

The Roles of FHL3 in Cancer.

The Roles of FHL3 in Cancer.

Journal: Frontiers in oncology

Published: March 02, 2022

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27.

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27.

Journal: BioMed research international

Published: April 30, 2021

The Emerging Roles of circFOXO3 in Cancer.

The Emerging Roles of circFOXO3 in Cancer.

Journal: Frontiers in cell and developmental biology

Published: January 27, 2021

The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.

The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.

Journal: Theranostics

Published: August 07, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026